Xueming Xu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Subject: Acknowledgement of letter regarding "Leukadherin-1 mitigates disseminated intravascular coagulation in acute pancreatitis by suppressing necroptosis".
Journal: Thrombosis research
Published: June 18, 2025
GSK461364 Inhibits NLRP3 Inflammasome by Targeting NEK7 Phosphorylation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 17, 2025
Revealing tumor microenvironment communication through m6A single-cell analysis and elucidating immunotherapeutic potentials for cutaneous melanoma (CM).
Journal: Journal of cancer research and clinical oncology
Published: February 05, 2025
Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases.
Journal: Acta pharmaceutica Sinica. B
Published: November 15, 2023
Acetylation is required for full activation of the NLRP3 inflammasome.
Journal: Nature communications
Published: April 04, 2023
An attack-defense game model in infrastructure networks under link hiding.
Journal: Chaos (Woodbury, N.Y.)
Published: December 01, 2022
C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome.
Journal: Frontiers in pharmacology
Published: May 10, 2021
CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity.
Journal: Experimental dermatology
Published: August 13, 2020
YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3.
Journal: Nature communications
Published: May 31, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026